The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways

Cell Death and Differentiation

Volumn 24, Issue 7, 2017, Pages 1153-1159

  Cohen, Philip ^a   Strickson, Sam ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

E3 LIGASE; LIGASE; LYSINE; MYELOID DIFFERENTIATION FACTOR 88; PELLINO PROTEIN; PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UNCLASSIFIED DRUG;

ENZYME ACTIVATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; METABOLISM;

ANIMALS; HUMANS; IMMUNITY, INNATE; LYSINE; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; UBIQUITIN; UBIQUITINATION;

EID: 85021381227     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2017.17     Document Type: Review

References (67)

1. Chau V, Tobias JW, Bachmair A, Marriott D, Ecker DJ, Gonda DK et al. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989; 243: 1576-1583.
2. Ciehanover A, Hod Y, Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun 1978; 81: 1100-1105.
3. Spence J, Sadis S, Haas AL, Finley D. A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol 1995; 15: 1265-1273.
4. Hofmann RM, Pickart CM. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell 1999; 96: 645-653.
5. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature 1996; 383: 443-446.
6. Lomaga MA, Yeh W-C, Sarosi I, Duncan GS, Furlonger C, Ho A et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13: 1015-1024.
7. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4: 353-362.
8. Deng L, Wang C, Spencer E, Yang L, Braun A, You J et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103: 351-361.
9. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346-351.
10. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, Matsumoto K. Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 2003; 22: 6277-6288.
11. Cheung PCF, Nebreda AR, Cohen P. TAB3, a new binding partner of the protein kinase TAK1. Biochem J 2004; 378: 27-34.
12. Shim J-H, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 2005; 19: 2668-2681.
13. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 2005; 6: 1087-1095.
14. Kanayama A, Seth RB, Sun L, Ea C-K, Hong M, Shaito A et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 2004; 15: 535-548.
15. Kulathu Y, Akutsu M, Bremm A, Hofmann K, Komander D. Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain. Nat Struct Mol Biol 2009; 16: 1328-1330.
16. Motshwene PG, Moncrieffe MC, Grossmann JG, Kao C, Ayaluru M, Sandercock AM et al. An oligomeric signaling platform formed by the toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 2009; 284: 25404-25411.
17. Lin S-C, Lo Y-C, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465: 885-890.
18. Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002; 418: 443-447.
19. Yin Q, Lin S, Lamothe B, Lu M. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009; 16: 658-666.
20. Smith H, Peggie M, Campbell DG, Vandermoere F, Carrick E, Cohen P. Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4. Proc Natl Acad Sci USA 2009; 106: 4584-4590.
21. Ordureau A, Smith H, Windheim M, Peggie M, Carrick E, Morrice N et al. The IRAKcatalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem J 2008; 409: 43-52.
22. Goh ETH, Arthur JSC, Cheung PCF, Akira S, Toth R, Cohen P. Identification of the protein kinases that activate the E3 ubiquitin ligase Pellino 1 in the innate immune system. Biochem J 2011; 441: 339-346.
23. Strickson S, Emmerich CH, Goh ETH, Zhang J, Kelsall IR, Macartney T et al. Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling. Proc Natl Acad Sci USA 2017; 10.1073/pnas.1702367114.
24. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 1998; 395: 297-300.
25. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 1998; 93: 1231-1240.
26. Ea C-K, Deng L, Xia Z-P, Pineda G, Chen ZJ. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245-257.
27. Wu C-J, Conze DB, Li T, Srinivasula SM, Ashwell JD. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [corrected]. Nat Cell Biol 2006; 8: 398-406.
28. Hubeau M, Ngadjeua F, Puel A, Israel L, Feinberg J, Chrabieh M et al. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein. Blood 2011; 118: 926-935.
29. Dffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat Genet 2001; 27: 277-285.
30. Kirisako T, Kamei K, Murata S, Kato M, Fukumoto H, Kanie M et al. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 2006; 25: 4877-4887.
31. Gerlach B, Cordier SM, Schmukle AC, Emmerich CH, Rieser E, Haas TL et al. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 2011; 471: 591-596.
32. Ikeda F, Deribe YL, Skanland SS, Stieglitz B, Grabbe C, Franz-Wachtel M et al. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 2011; 471: 637-641.
33. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, Sakata S et al. SHARPIN is a component of the NF-κB-Activating linear ubiquitin chain assembly complex. Nature 2011; 471: 633-636.
34. Lo Y-C, Lin S-C, Rospigliosi CC, Conze DB, Wu C-J, Ashwell JD et al. Structural basis for recognition of diubiquitins by NEMO. Mol Cell 2009; 33: 602-615.
35. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, Kato R et al. Specific recognition of linear ubiquitin chains by NEMO is important for NF-κB activation. Cell 2009; 136: 1098-1109.
36. Emmerich CH, Ordureau A, Strickson S, Arthur JSC, Pedrioli PGA, Komander D et al. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci USA 2013; 110: 15247-15252.
37. Zhang J, Clark K, Lawrence T, Peggie MW, Cohen P. An unexpected twist to the activation of IKKβ: TAK1 primes IKKβ for activation by autophosphorylation. Biochem J 2014; 461: 531-537.
38. Tokunaga F, Sakata S, Saeki Y, Satomi Y, Kirisako T, Kamei K et al. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat Cell Biol 2009; 11: 123-132.
39. Kensche T, Tokunaga F, Ikeda F, Goto E, Iwai K, Dikic I. Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB. J Biol Chem 2012; 287: 23626-23634.
40. Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006; 2006: re13.
41. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T et al. Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature 2005; 434: 243-249.
42. Lopez-Pelaez M, Lamont DJ, Peggie M, Shpiro N, Gray NS, Cohen P. Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells. Proc Natl Acad Sci USA 2014; 111: 17432-17437.
43. Ren J, Chen X, Chen ZJ. IKKβ is an IRF5 kinase that instigates inflammation. Proc Natl Acad Sci USA 2014; 111: 17438-17443.
44. Lang V, Symons A, Watton SJ, Janzen J, Soneji Y, Beinke S et al. ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability. Mol Cell Biol 2004; 24: 5235-5248.
45. Aoki M, Hamada F, Sugimoto T, Sumida S, Akiyama T, Toyoshima K. The human cot protooncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J Biol Chem 1993; 268: 22723-22732.
46. Beinke S, Robinson MJ, Hugunin M, Ley SC. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-Activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol Cell Biol 2004; 24: 9658-9667.
47. Waterfield M, Jin W, Reiley W, Zhang M, Sun S-C. IκB kinase is an essential component of the Tpl2 signaling pathway. Mol Cell Biol 2004; 24: 6040-6048.
48. Ben-Addi A, Mambole-Dema A, Brender C, Martin SR, Janzen J, Kjaer S et al. I B kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for toll-like receptor activation of ERK-1 and-2 MAP kinases. Proc Natl Acad Sci USA 2014; 111: E2394-E2403.
49. Pattison MJ, Mitchell O, Flynn HR, Chen C-S, Yang H-T, Ben-Addi H et al. TLR and TNF-R1 activation of the MKK3/MKK6-p38α axis in macrophages is mediated by TPL-2 kinase. Biochem J 2016; 473: 2845-2861.
50. Arthur JSC, Ley SC. Mitogen-Activated protein kinases in innate immunity. Nat Rev Immunol 2013; 13: 679-692.
51. Heyninck K, Kreike MM, Beyaert R. Structure-function analysis of the A20-binding inhibitor of NF-κB activation, ABIN-1. FEBS Lett 2003; 536: 135-140.
52. Lork M, Verhelst K, Beyaert R. CYLD, A20 and OTULIN deubiquitinases in inflammation and cell death, so similar yet so different. Cell Death Differ 2017; e-pub ahead of print 31 March 2017; doi: 10.1038/cdd.2017.46.
53. Haas TL, Emmerich CH, Gerlach B, Schmukle AC, Cordier SM, Rieser E et al. Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 2009; 36: 831-844.
54. Sato Y, Fujita H, Yoshikawa A, Yamashita M, Yamagata A, Kaiser SE et al. Specific recognition of linear ubiquitin chains by the Npl4 zinc finger (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly complex. Proc Natl Acad Sci USA 2011; 108: 20520-20525.
55. Emmerich CH, Bakshi S, Kelsall IR, Ortiz-Guerrero J, Shpiro N, Cohen P. Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling. Biochem Biophys Res Commun 2016; 474: 452-461.
56. Fiil BK, Damgaard RB, Wagner SA, Keusekotten K, Fritsch M, Bekker-Jensen S et al. OTULIN restricts Met1-linked ubiquitination to control innate immune signaling. Mol Cell 2013; 50: 818-830.
57. Nanda SK, Venigalla RKC, Ordureau A, Patterson-Kane JC, Powell DW, Toth R et al. Polyubiquitin binding to ABIN1 is required to prevent autoimmunity. J Exp Med 2011; 208: 1215-1228.
58. Nanda SK, Lopez-Pelaez M, Arthur JSC, Marchesi F, Cohen P. Suppression of IRAK1 or IRAK4 catalytic activity, but not type 1 IFN signaling, prevents lupus nephritis in mice expressing a ubiquitin binding-defective mutant of ABIN1. J Immunol 2016; 197: 4266-4273.
59. Skaug B, Chen J, Du F, He J, Ma A, Chen ZJ. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell 2011; 44: 559-571.
60. Bosanac I, Wertz IE, Pan B, Yu C, Kusam S, Lam C et al. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling. Mol Cell 2010; 40: 548-557.
61. Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K et al. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J 2012; 31: 3856-3870.
62. Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, Kensche T et al. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J 2012; 31: 3845-3855.
63. Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W et al. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP-or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J Cell Biol 1999; 145: 1471-1482.
64. Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity. J Biol Chem 2009; 284: 8217-8221.
65. Dong G, Chanudet E, Zeng N, Appert A, Chen Y-W, Au W-Y et al. A20, ABIN-1/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma. Clin Cancer Res 2011; 17: 1440-1451.
66. Wertz IE, Newton K, Seshasayee D, Kusam S, Lam C, Zhang J et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 2015; 528: 370-375.
67. De A, Dainichi T, Rathinam CV, Ghosh S. The deubiquitinase activity of A20 is dispensable for NF-κB signaling. EMBO Rep 2014; 15: 775-783.